Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01787864 · ClinicalTrials.gov registry record
Prevalence of Dysplasia of the Gastric Cardia
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 170
- Enrollment target
NCT01787864 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 170 participants.
The verdict
NCT01787864 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
Study Summary
We propose a tissue sample collection study for patients at UNC who have undergone or will undergo radiofrequency ablation therapy for Barrett's Esophagus (BE) or intramucosal adenocarcinoma as part of routine medical care. Purpose: To determine the prevalence of metaplasia and dysplasia in the gastric cardia before and after ablative therapy. To determine the incidence of cardiac metaplasia and dysplasia as a function of ablative therapy. To determine the correlation between dysplasia in the tubular esophagus, and dysplasia in the cardia. To assess the ability of immunohistochemical (IHC) staining of cardia tissues to predict incident dysplasia in the cardia. Several well-characterized biomarkers, including p16, p53, Ki67, cyclin D1, and cyclin A, will be assessed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2013-02 |
| Est. Completion | 2017-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01787864
The ClinicalTrials.gov registry entry for NCT01787864 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01787864 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01787864 about?
NCT01787864 is a clinical study titled "Prevalence of Dysplasia of the Gastric Cardia". We propose a tissue sample collection study for patients at UNC who have undergone or will undergo radiofrequency ablation therapy for Barrett's Esophagus (BE) or intramucosal adenocarcinoma as part of routine medical care. Purpose: To determine the prevalence of metaplasia and dysplasia in the ga...
What is the current status of trial NCT01787864?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2013-02. Estimated completion is 2017-05.
Who is sponsoring clinical trial NCT01787864?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.